Related Experiment Video
Updated: May 8, 2026
15:31
MISSION esiRNA for RNAi Screening in Mammalian Cells
Published on: May 12, 2010
Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.
A Guzman-Aranguez1, P Loma, J Pintor
1Department of Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, Universidad Complutense de Madrid, Madrid, Spain.
British Journal of Pharmacology
|August 14, 2013
Summary
RNA interference (RNAi) offers a promising therapeutic approach for eye diseases by silencing specific genes. Advances in delivery methods are crucial for enhancing the efficacy of small interfering RNAs (siRNAs) in treating ocular disorders.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- RNA interference (RNAi) is a powerful tool for gene function research and therapeutic development.
- The eye's unique anatomy facilitates local delivery of RNAi therapeutics, such as small interfering RNAs (siRNAs).
- Ocular disorders like glaucoma and age-related macular degeneration are potential targets for RNAi-based treatments.
Purpose of the Study:
- To review the current progress of RNA interference in ocular therapeutics.
- To discuss the advantages and limitations of RNAi-based treatments for eye diseases.
- To highlight the importance of improved delivery strategies for siRNA efficacy.
Main Methods:
- Review of experimental animal models for RNAi in glaucoma, retinitis pigmentosa, and neovascular eye diseases.
- Analysis of ongoing and completed clinical trials for ocular RNAi therapies.
- Discussion of siRNA delivery strategies and their impact on therapeutic efficacy.
Main Results:
- siRNAs targeting key pathogenic molecules have shown promise in preclinical models.
- Clinical trials are underway for several RNAi-based ocular therapies.
- Effective delivery systems are essential for overcoming siRNA degradation and achieving long-term treatment benefits.
Conclusions:
- RNAi holds significant potential for treating a range of ocular pathologies.
- Further development of delivery technologies is critical for realizing the full therapeutic benefits of RNAi in ophthalmology.
- RNAi-based therapies offer a novel alternative to existing treatments for various eye conditions.
Keywords:
age-related macular degenerationcorneal neovascularizationdiabetic retinopathyeyeglaucomaretinitis pigmentosasiRNAstherapyMore Related Videos
05:28A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System
Published on: August 15, 2019
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...